Pharma IQ Members


Co-Crystals are defined as a technology used to enhance solubility, stability and the IP position with respect to the development of active pharmaceutical ingredients (APIs). Exploring the co-crystallization potential around an API increases the intellectual property protection over a particular drug product; thus, reducing the risk of costly litigation and market erosion.

Helen Winsor

Prof. Nair Rodriguez-Hornedo of the University of Michigan, discusses the latest successful strategies in making co-crystals, providing firsthand examples from the University's Department of Pharmaceutical Sciences. She offers her perspective on...

Contributor: Helen Winsor
Sat, 07/10/2010
Be Prepared for Scale Up of Co-crystal Production

Dr. Vaibhav Sihorkar, Head of Pharmaceutical Development at Aurigene Discovery Technologies in India, gave Pharma IQ his insights on existing challenges to co-crystal commercialisation.What is the major challenge in achieving scale up of co-...

Contributor: Vaibhav Sihorkar
Tue, 07/06/2010